Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FF611
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order (Contract 4569783058), valued at $4,169.59 and awarded on October 20, 2025, was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, funded by the Defense Logistics Agency's Medical Supply Chain division. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical devices.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, structured as a 30-month base period with three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group serves as a regional prime vendor contractor authorized to fulfill recurring pharmaceutical supply requirements for military medical facilities worldwide, supporting the Department of Defense's global healthcare operations with specialized and diverse pharmaceutical products and services.
Quick answers
Who was awarded contract SPE2DX26FF611?
SPE2DX26FF611 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 20, 2025.
How much is contract SPE2DX26FF611 worth?
The government has obligated $4,170 on SPE2DX26FF611.
Is contract SPE2DX26FF611 an order under another contract?
Yes. SPE2DX26FF611 is a delivery order under SPE2DX16D9410, an indefinite delivery contract.
Was contract SPE2DX26FF611 competed?
The extent of competition for SPE2DX26FF611 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award